BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37406882)

  • 1. Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia.
    Abid MB; Estrada-Merly N; Zhang MJ; Chen K; Allan D; Bredeson C; Sabloff M; Guru Murthy GS; Badar T; Hashmi S; Aljurf M; Litzow MR; Kebriaei P; Hourigan CS; Saber W
    Transplant Cell Ther; 2023 Sep; 29(9):578.e1-578.e9. PubMed ID: 37406882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Abid MB; Estrada-Merly N; Zhang MJ; Chen K; Bredeson C; Allan D; Sabloff M; Marks DI; Litzow M; Hourigan C; Kebriaei P; Saber W
    Transplant Cell Ther; 2023 Oct; 29(10):611-618. PubMed ID: 37481243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
    Pereira MP; Remberger M; Chen C; Gerbitz A; Kim DDH; Kumar R; Lam W; Law AD; Lipton JH; Michelis FV; Novitzky-Basso I; Viswabandya A; Mattsson J; Pasic I
    Transplant Cell Ther; 2023 Nov; 29(11):697.e1-697.e10. PubMed ID: 37579919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status.
    Konuma T; Yamasaki S; Ishiyama K; Mizuno S; Hayashi H; Uchida N; Shimabukuro M; Tanaka M; Kuriyama T; Onizuka M; Ishiwata K; Sawa M; Tanaka T; Ohigashi H; Fujiwara SI; Matsuoka KI; Ota S; Nishida T; Kanda Y; Fukuda T; Atsuta Y; Nakasone H; Yanada M;
    Transplant Cell Ther; 2024 Feb; 30(2):215.e1-215.e18. PubMed ID: 38081415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.
    Mehta RS; Ramdial J; Marin D; Alousi A; Kanakry CG; Champlin RE; Rezvani K; Shpall EJ; Page K; Gadalla SM; Kebriaei P; Weisdorf D
    Transplant Cell Ther; 2023 Jun; 29(6):377.e1-377.e7. PubMed ID: 36990221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study.
    Gao L; Yang L; Zhou S; Zhu W; Han Y; Chen S; Xue S; Wang Y; Qiu H; Wu D; Wu X
    Stem Cell Res Ther; 2024 Jan; 15(1):24. PubMed ID: 38282037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study.
    Bejanyan N; Weisdorf DJ; Logan BR; Wang HL; Devine SM; de Lima M; Bunjes DW; Zhang MJ
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):454-9. PubMed ID: 25460355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis.
    Kim HT; Ho VT; Nikiforow S; Cutler C; Koreth J; Shapiro RM; Gooptu M; Romee R; Wu CJ; Antin JH; Ritz J; Soiffer RJ
    Transplant Cell Ther; 2024 May; ():. PubMed ID: 38703824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
    Maffini E; Labopin M; Kröger N; Finke J; Stelljes M; Schroeder T; Einsele H; Tischer J; Bornhäuser M; Bethge W; Brecht A; Rösler W; Dreger P; Schäfer-Eckart K; Passweg J; Blau IW; Nagler A; Ciceri F; Mohty M
    Bone Marrow Transplant; 2024 Mar; ():. PubMed ID: 38555412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes and Treatment Patterns in Adults With FLT3-ITD
    Pandya BJ; Burns LJ; Wang T; Xie B; Touya M; Spalding J; Block A; Kuperman G; Young C
    Transplant Cell Ther; 2024 Apr; ():. PubMed ID: 38663769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
    Saliba RM; Kanakry CG; Gadalla S; Kebriaei P; Rezvani K; Champlin RE; Shpall EJ; Weisdorf D; Mehta RS
    Am J Hematol; 2024 Jan; 99(1):38-47. PubMed ID: 37850688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor
    Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
    Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
    Chhabra S; Visotcky A; Pasquini MC; Zhu F; Tang X; Zhang MJ; Thompson R; Abedin S; D'Souza A; Dhakal B; Drobyski WR; Fenske TS; Jerkins JH; Douglas Rizzo J; Runaas L; Saber W; Shah NN; Shaw BE; Horowitz MM; Hari PN; Hamadani M
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1876-1885. PubMed ID: 32653622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.
    Guru Murthy GS; Logan BR; Bo-Subait S; Beitinjaneh A; Devine S; Farhadfar N; Gowda L; Hashmi S; Lazarus H; Nathan S; Sharma A; Yared JA; Stefanski HE; Pulsipher MA; Hsu JW; Switzer GE; Panch SR; Shaw BE
    Am J Hematol; 2023 Apr; 98(4):608-619. PubMed ID: 36606713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry.
    Gillis N; Padron E; Wang T; Chen K; DeVos JD; Spellman SR; Lee SJ; Kitko CL; MacMillan ML; West J; Tang YH; Teng M; McNulty S; Druley TE; Pidala JA; Lazaryan A
    Transplant Cell Ther; 2023 Oct; 29(10):640.e1-640.e8. PubMed ID: 37517612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.
    Ustun C; Le-Rademacher J; Wang HL; Othus M; Sun Z; Major B; Zhang MJ; Storrick E; Lafky JM; Chow S; Mrózek K; Attar EC; Nand S; Bloomfield CD; Cripe LD; Tallman MS; Appelbaum F; Larson RA; Marcucci G; Roboz GJ; Uy GL; Stone RM; Jatoi A; Shea TC; de Lima M; Foran JM; Sandmaier BM; Litzow MR; Erba HP; Hurria A; Weisdorf DJ; Artz AS
    Leukemia; 2019 Nov; 33(11):2599-2609. PubMed ID: 31073153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Total Body Irradiation on Hematopoietic Cell Transplantation Outcomes in Pediatric Acute Myeloid Leukemia with Prior Central Nervous System Involvement.
    Takahashi T; Lake AJ; Wachter F; Calderon FA; Dandoy C; Keating AK
    Transplant Cell Ther; 2024 May; ():. PubMed ID: 38763417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence.
    Cohen S; Bambace N; Ahmad I; Roy J; Tang X; Zhang MJ; Burns L; Barabé F; Bernard L; Delisle JS; Kiss T; Lachance S; Roy DC; Veilleux O; Sauvageau G
    Blood Adv; 2023 Oct; 7(19):5717-5726. PubMed ID: 37467030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
    Percival ME; Wang HL; Zhang MJ; Saber W; de Lima M; Litzow M; Kebriaei P; Abdel-Azim H; Adekola K; Aljurf M; Bacher U; Badawy SM; Beitinjaneh A; Bejanyan N; Bhatt V; Byrne M; Cahn JY; Castillo P; Chao N; Chhabra S; Copelan E; Cutler C; DeFilipp Z; Dias A; Diaz MA; Estey E; Farhadfar N; Frangoul HA; Freytes CO; Gale RP; Ganguly S; Gowda L; Grunwald M; Hossain N; Kamble RT; Kanakry CG; Kansagra A; Kharfan-Dabaja MA; Krem M; Lazarus HM; Lee JW; Liesveld JL; Lin R; Liu H; McGuirk J; Munker R; Murthy HS; Nathan S; Nishihori T; Olsson RF; Palmisiano N; Passweg JR; Prestidge T; Ringdén O; Rizzieri DA; Rybka WB; Savoie ML; Schultz KR; Seo S; Sharma A; Solh M; Strair R; van der Poel M; Verdonck LF; Yared JA; Weisdorf D; Sandmaier BM
    Bone Marrow Transplant; 2021 Sep; 56(9):2108-2117. PubMed ID: 33864019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study.
    Baena JC; Rosales MC; Estacio M; Hidalgo A; Arrieta E; Jaramillo FJ; Manzi E; Parra-Lara LG; Rosales JD
    J Hematol; 2023 Dec; 12(6):255-267. PubMed ID: 38188474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.